GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Meta Growth Corp (FRA:1HV) » Definitions » Debt-to-EBITDA

Meta Growth (FRA:1HV) Debt-to-EBITDA : -0.52 (As of May. 2020)


View and export this data going back to 2017. Start your Free Trial

What is Meta Growth Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Meta Growth's Short-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2020 was €1.57 Mil. Meta Growth's Long-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2020 was €26.48 Mil. Meta Growth's annualized EBITDA for the quarter that ended in May. 2020 was €-53.68 Mil. Meta Growth's annualized Debt-to-EBITDA for the quarter that ended in May. 2020 was -0.52.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Meta Growth's Debt-to-EBITDA or its related term are showing as below:

FRA:1HV's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.66
* Ranked among companies with meaningful Debt-to-EBITDA only.

Meta Growth Debt-to-EBITDA Historical Data

The historical data trend for Meta Growth's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meta Growth Debt-to-EBITDA Chart

Meta Growth Annual Data
Trend Dec15 Dec16 Aug17 Aug18 Aug19
Debt-to-EBITDA
N/A - -0.05 -3.19 -0.96

Meta Growth Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.16 -0.45 -4.20 -5.35 -0.52

Competitive Comparison of Meta Growth's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Meta Growth's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meta Growth's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Meta Growth's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Meta Growth's Debt-to-EBITDA falls into.



Meta Growth Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Meta Growth's Debt-to-EBITDA for the fiscal year that ended in Aug. 2019 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6.161 + 11.63) / -18.508
=-0.96

Meta Growth's annualized Debt-to-EBITDA for the quarter that ended in May. 2020 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.571 + 26.483) / -53.68
=-0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (May. 2020) EBITDA data.


Meta Growth  (FRA:1HV) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Meta Growth Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Meta Growth's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Meta Growth (FRA:1HV) Business Description

Traded in Other Exchanges
N/A
Address
56 Aberfoyle Crescent, Suite 200, Toronto, ON, CAN, M8X 2W4
Meta Growth Corp is a retailer of legal recreational cannabis in Canada. Through its Canada-wide network of Meta Cannabis Co, Meta Cannabis Supply Co, and NewLeaf Cannabis recreational cannabis retail stores, Meta Growth enables the public to gain knowledgeable access to Canada's network of authorized Licensed Producers of cannabis.

Meta Growth (FRA:1HV) Headlines

No Headlines